![News](https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/23084701/hero-banner.jpg)
Posts Tagged ‘common cold’
Channel 7 shines a spotlight on Firebrick’s Phase 3 common cold trial for Nasodine
17 May 2022
Firebrick Pharma’s Dr Peter Molloy and Dr Chris Rock from CMAX Clinical Research discuss with Channel 7 the start of our Phase 3 common cold trial for Nasodine® Nasal Spray. Adelaide is the first location for the trial, with sites in Victoria and South Africa to follow. If you live in South Australia or Victoria,…